Common use of Sublicensee and Transferee Gross Revenue Clause in Contracts

Sublicensee and Transferee Gross Revenue. Biovest shall cause each Sublicensee and Transferee to pay to Company, or its assigns, a perpetual contingent payment equal to one percent (1.00%%) of the Gross Revenue derived from the sale, license or other disposition of the Biovest Biologic Products received by Sublicensees and Transferees (the “Sublicensee/Transferee Contingent Payment”, and together with the Biovest Contingent Payment, the “Contingent Payments”). For the avoidance of doubt, no contingent payment right is granted to Company hereunder with regard to any Biovest activity other than the Biovest Biologic Products, and no right, interest, or license to use any Biovest Biologic Product (or other product or intellectual property of Biovest or its Affiliates) is granted under this Agreement whatsoever.

Sublicensee and Transferee Gross Revenue. Biovest shall cause each Sublicensee and Transferee to pay to Company, or its assigns, a perpetual contingent payment equal to one percent (1.00%%) 49.76% of the Gross Revenue derived from the sale, license or other disposition of the Aggregate Biovest Biologic Products received by Sublicensees and Transferees Sublicensee/Transferee Contingent Payment (the “Sublicensee/Transferee Contingent Payment”, and ” together with the Biovest Contingent Payment, the “Contingent Payments”). For the avoidance of doubt, no contingent payment right is granted to Company hereunder with regard to any Biovest activity other than the Biovest Biologic Products, and no right, interest, or license to use any Biovest Biologic Product (or other product or intellectual property of Biovest or its Affiliates) is granted under this Agreement whatsoever.

Sublicensee and Transferee Gross Revenue. Biovest shall cause each Sublicensee and Transferee to pay to Company, or its assigns, a perpetual contingent payment equal to one percent (1.00%%) 2.08% of the Gross Revenue derived from the sale, license or other disposition of the Aggregate Biovest Biologic Products received by Sublicensees and Transferees Sublicensee/Transferee Contingent Payment (the “Sublicensee/Transferee Contingent Payment”, and ” together with the Biovest Contingent Payment, the “Contingent Payments”). For the avoidance of doubt, no contingent payment right is granted to Company hereunder with regard to any Biovest activity other than the Biovest Biologic Products, and no right, interest, or license to use any Biovest Biologic Product (or other product or intellectual property of Biovest or its Affiliates) is granted under this Agreement whatsoever.

Sublicensee and Transferee Gross Revenue. Biovest shall cause each Sublicensee and Transferee to pay to Company, or its assigns, a perpetual contingent payment equal to one percent (1.00%%) 25.92% of the Gross Revenue derived from the sale, license or other disposition of the Aggregate Biovest Biologic Products received by Sublicensees and Transferees Sublicensee/Transferee Contingent Payment (the “Sublicensee/Transferee Contingent Payment”, and ” together with the Biovest Contingent Payment, the “Contingent Payments”). For the avoidance of doubt, no contingent payment right is granted to Company hereunder with regard to any Biovest activity other than the Biovest Biologic Products, and no right, interest, or license to use any Biovest Biologic Product (or other product or intellectual property of Biovest or its Affiliates) is granted under this Agreement whatsoever.

Sublicensee and Transferee Gross Revenue. Biovest shall cause each Sublicensee and Transferee to pay to Company, or its assigns, a perpetual contingent payment equal to one percent (1.00%%) 8.96% of the Gross Revenue derived from the sale, license or other disposition of the Aggregate Biovest Biologic Products received by Sublicensees and Transferees Sublicensee/Transferee Contingent Payment (the “Sublicensee/Transferee Contingent Payment”, and ” together with the Biovest Contingent Payment, the “Contingent Payments”). For the avoidance of doubt, no contingent payment right is granted to Company hereunder with regard to any Biovest activity other than the Biovest Biologic Products, and no right, interest, or license to use any Biovest Biologic Product (or other product or intellectual property of Biovest or its Affiliates) is granted under this Agreement whatsoever.

Sublicensee and Transferee Gross Revenue. Biovest shall cause each Sublicensee and Transferee to pay to Company, or its assigns, a perpetual contingent payment equal to one percent (1.00%%) 13.28% of the Gross Revenue derived from the sale, license or other disposition of the Aggregate Biovest Biologic Products received by Sublicensees and Transferees Sublicensee/Transferee Contingent Payment (the “Sublicensee/Transferee Contingent Payment”, and ” together with the Biovest Contingent Payment, the “Contingent Payments”). For the avoidance of doubt, no contingent payment right is granted to Company hereunder with regard to any Biovest activity other than the Biovest Biologic Products, and no right, interest, or license to use any Biovest Biologic Product (or other product or intellectual property of Biovest or its Affiliates) is granted under this Agreement whatsoever.